Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy of Antioxidants Alone Versus Combined Therapy With SERMs or FSH in Normogonadotropic Idiopathic OAT Patients: A Randomized Controlled Trial

NCT07862725 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT07862725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07862725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy of Antioxidants Alone Versus Combined Therapy With SERMs or FSH in Normogonadotropic Idiopathic OAT Patients: A Randomized Controlled Trial
Lead sponsor
Hamad Medical Corporation
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
October 15, 2028
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male infertility, oligoasthenoteratozoospermia